Jaguar Health, Inc. Note Agreements

30 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Jaguar Health, Inc. Convertible Promissory Note Issued to Investor under Securities Purchase Agreement
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2025
Amendment to Secured Promissory Note between Streeterville Capital, LLC, Jaguar Health, Inc., and Napo Pharmaceuticals, Inc.
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
2025
Note Purchase Agreement between Jaguar Health, Inc., Napo Pharmaceuticals, Inc., and Streeterville Capital, LLC (January 19, 2021)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2021
Secured Promissory Note between Jaguar Health, Inc., Napo Pharmaceuticals, Inc., and Streeterville Capital, LLC dated January 19, 2021
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2021
Unsecured Promissory Note between Jaguar Health, Inc., Napo Pharmaceuticals, Inc., and Michael Tempesta dated October 1, 2019
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2019
First Amendment to Promissory Note between Jaguar Health, Inc. and Holder (2019)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
2019
Secured Promissory Note, dated May 28, 2019, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Secured Promissory Note, dated May 28, 2019, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2019
Form of 125% Coverage Promissory Note
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2019
Form of 75% Coverage Promissory Note
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2019
Jaguar Health, Inc. Convertible Promissory Note Issued to Charles Conte Dated September 11, 2018
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Convertible Promissory Note between Jaguar Health, Inc. and L2 Capital, LLC dated September 11, 2018
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
NY
2018
Secured Promissory Note between Jaguar Health, Inc. and Chicago Venture Partners, L.P. dated March 21, 2018
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Secured Promissory Note between Jaguar Health, Inc. and Chicago Venture Partners, L.P. dated February 26, 2018
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2018
Second Amendment to Note Purchase Agreement and Notes and Payoff Agreement between Napo Pharmaceuticals, Inc. and Note Purchasers
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2018
Second Amended Original Issue Discount Exchangeable Promissory Note between Napo Pharmaceuticals, Inc. and Holder (Due May 1, 2018)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
First Amendment to Note Purchase Agreement and Notes by Napo Pharmaceuticals, Inc. and Purchasers
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
First Amended Original Issue Discount Exchangeable Promissory Note between Napo Pharmaceuticals, Inc. and Holder (2017)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2018
Secured Promissory Note between Jaguar Health, Inc. and Chicago Venture Partners, L.P. dated December 8, 2017
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
Secured Convertible Promissory Note between Jaguar Animal Health, Inc. and Chicago Venture Partners, L.P. dated June 29, 2017
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
UT
2017
Convertible Promissory Note between Napo Pharmaceuticals, Inc. and Holder under Amended and Restated Note Purchase Agreement
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
Amended and Restated Note Purchase Agreement between Napo Pharmaceuticals, Inc. and Kingdon Entities (March 31, 2017)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
Napo Pharmaceuticals, Inc. Exchangeable Promissory Note Due December 2017
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
Note Purchase Agreement between Napo Pharmaceuticals, Inc. and Purchasers (March 1, 2017)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2017
Jaguar Animal Health and Serious Change II LP Convertible Promissory Note and Warrant Agreement
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2017
Jaguar Animal Health and Serious Change II LP Convertible Note Repayment and Warrant Agreement
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
CA
2016
Jaguar Animal Health, Inc. Convertible Promissory Note with Dechra Pharmaceuticals PLC (March 20, 2015)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2015
Jaguar Animal Health, Inc. Note Exercise Amendment and Conversion Agreement
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
Jaguar Animal Health, Inc. Convertible Note Exercise Amendment (March 2015)
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
2015
Jaguar Animal Health, Inc. Convertible Promissory Note Agreement
Note Agreements
Jaguar Health, Inc.
Pharmaceuticals
DE
2015